Calcikor
Natural health product licensed in Canada
- Licence holder
- Wampole Group L.P.
- NPN or DIN-HM
- 02241184
- Status
- Active licence
- Licence date
- 7 December 2007
- Revision date
- 15 September 2026
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Calcium Source : Carbonate de calcium | 333 mg | 666,000 µg |
Non-medicinal ingredients
Stéarate de magnésium, Cellulose, microcristalline, Hypromellose, Eau purifiée, Dioxyde de titanium, Croscarmellose de sodium, Poly(dextrose), Talc, Gomme-laque, sel d'ammonium, triglycérides à chaînes moyennes
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Multi-vitamin/mineral supplement. A factor in the maintenance of good health. Helps in the development and maintenance of bones and teeth, in tissue and connective tissue formation, in the maintenance of healthy skin, immune function and proper muscle function and in the absorption and use of calcium and phosphorus. Calcium intake, when combined with sufficient vitamin D, a healthy diet, and a regular exercise, may reduce the risk of developing osteoporosis. Helps the body to metabolize carbohydrates and fats and proteins, to form red blood cells and in their proper function, to prevent vitamin B12 deficiency and to reduce the risk of neural tube defects when taken daily prior to becoming pregnant and during early pregnancy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02241184
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.